Mauro, M J, Hughes, T P, Kim, D-W, Rea, D, Cortes, J E, Hochhaus, A, Sasaki, K, Breccia, M, Talpaz, M, Ottmann, O, Minami, H, Goh, Y T, DeAngelo, D J, Heinrich, M C, Gómez-García de Soria, V, le Coutre, P, Mahon, F-X, Janssen, J J W M, Deininger, M, Shanmuganathan, N, Geyer, M B, Cacciatore, S, Polydoros, F, Agrawal, N, Hoch, M & Lang, F 2023, ' Asciminib monotherapy in patients with CML-CP without BCR : :ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results ', Leukemia, vol. 37, no. 5, pp. 1048-1059 . https://doi.org/10.1038/s41375-023-01860-w Leukemia, 37(5), 1048-1059. Nature Publishing Group